Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehmet Altan

Showing results (41-50 of 153) with videos related to

Pageof 16
Sort By:
Journal of Cancer Research and Clinical Oncology|August 28, 2022
Clinical characteristics and outcomes of tyrosine kinase inhibitor-related lower GI adverse effectsCynthia Liu, Rajan Amin, Malek Shatila, et al.
Ophthalmic Plastic and Reconstructive Surgery|October 27, 2018
Impact of Food and Drug Administration Approval of Vismodegib on Prevalence of Orbital Exenteration as a Necessary Surgical Treatment for Locally Advanced Periocular Basal Cell CarcinomaOded Sagiv, Stephanie Ding, Renata Ferrarotto, et al.
NPJ Breast Cancer|March 22, 2018
An assessment of neuronal calcium sensor-1 and response to neoadjuvant chemotherapy in breast cancer patientsLauren M Moore, Rachel Wilkinson, Mehmet Altan, et al.
Journal for Immunotherapy of Cancer|September 7, 2019
Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitisHamzah Abu-Sbeih, Lauren Nicholas Herrera, Tenglong Tang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 25, 2016
EGFR-GRB2 Protein Colocalization Is a Prognostic Factor Unrelated to Overall EGFR Expression or EGFR Mutation in Lung AdenocarcinomaMaria I Toki, Daniel E Carvajal-Hausdorf, Mehmet Altan, et al.
Cancers|August 10, 2024
The Effect of Immune Checkpoint Inhibitor Therapy on Pre-Existing Gastroparesis and New Onset of Symptoms of Delayed Gastric EmptyingAndres C Urias Rivera, Antonio Pizuorno Machado, Malek Shatila, et al.
Oncology Letters|May 22, 2023
Clinical outcomes of immunotherapy continued beyond radiographic disease progression in older adult patients with advanced non‑small cell lung cancerEric K Singhi, Frank Mott, Michelle Worst, et al.
Briefings in Bioinformatics|June 20, 2023
A novel statistical method for decontaminating T-cell receptor sequencing dataRuoxing Li, Mehmet Altan, Alexandre Reuben, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 10, 2019
Immune Checkpoint Inhibitor-Associated PericarditisMehmet Altan, Maria I Toki, Scott N Gettinger, et al.
Journal of Cancer Research and Clinical Oncology|January 7, 2023
Characteristics, treatment, and outcome of patients with bowel perforation after immune checkpoint inhibitor exposureAntonio Pizuorno Machado, Malek Shatila, Cynthia Liu, et al.
Pageof 16

Showing results (41-50 of 153) with videos related to

Sort By:
Pageof 16
Journal of Cancer Research and Clinical Oncology|August 28, 2022
Clinical characteristics and outcomes of tyrosine kinase inhibitor-related lower GI adverse effectsCynthia Liu, Rajan Amin, Malek Shatila, et al.
Ophthalmic Plastic and Reconstructive Surgery|October 27, 2018
Impact of Food and Drug Administration Approval of Vismodegib on Prevalence of Orbital Exenteration as a Necessary Surgical Treatment for Locally Advanced Periocular Basal Cell CarcinomaOded Sagiv, Stephanie Ding, Renata Ferrarotto, et al.
NPJ Breast Cancer|March 22, 2018
An assessment of neuronal calcium sensor-1 and response to neoadjuvant chemotherapy in breast cancer patientsLauren M Moore, Rachel Wilkinson, Mehmet Altan, et al.
Journal for Immunotherapy of Cancer|September 7, 2019
Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitisHamzah Abu-Sbeih, Lauren Nicholas Herrera, Tenglong Tang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 25, 2016
EGFR-GRB2 Protein Colocalization Is a Prognostic Factor Unrelated to Overall EGFR Expression or EGFR Mutation in Lung AdenocarcinomaMaria I Toki, Daniel E Carvajal-Hausdorf, Mehmet Altan, et al.
Cancers|August 10, 2024
The Effect of Immune Checkpoint Inhibitor Therapy on Pre-Existing Gastroparesis and New Onset of Symptoms of Delayed Gastric EmptyingAndres C Urias Rivera, Antonio Pizuorno Machado, Malek Shatila, et al.
Oncology Letters|May 22, 2023
Clinical outcomes of immunotherapy continued beyond radiographic disease progression in older adult patients with advanced non‑small cell lung cancerEric K Singhi, Frank Mott, Michelle Worst, et al.
Briefings in Bioinformatics|June 20, 2023
A novel statistical method for decontaminating T-cell receptor sequencing dataRuoxing Li, Mehmet Altan, Alexandre Reuben, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 10, 2019
Immune Checkpoint Inhibitor-Associated PericarditisMehmet Altan, Maria I Toki, Scott N Gettinger, et al.
Journal of Cancer Research and Clinical Oncology|January 7, 2023
Characteristics, treatment, and outcome of patients with bowel perforation after immune checkpoint inhibitor exposureAntonio Pizuorno Machado, Malek Shatila, Cynthia Liu, et al.
Pageof 16